Literature DB >> 17130494

Nutrient control of insulin secretion in isolated normal human islets.

Jean-Claude Henquin1, Denis Dufrane, Myriam Nenquin.   

Abstract

Pancreatic islets were isolated from 16 nondiabetic organ donors and, after culture for approximately 2 days in 5 mmol/l glucose, were perifused to characterize nutrient-induced insulin secretion in human islets. Stepwise increases from 0 to 30 mmol/l glucose (eight 30-min steps) evoked concentration-dependent insulin secretion with a threshold at 3-4 mmol/l glucose, K(m) at 6.5 mmol/l glucose, and V(max) at 15 mmol/l glucose. An increase from 1 to 15 mmol/l glucose induced biphasic insulin secretion with a prominent first phase (peak increase of approximately 18-fold) and a sustained, flat second phase ( approximately 10-fold increase), which were both potentiated by forskolin. The central role of ATP-sensitive K(+) channels in the response to glucose was established by abrogation of insulin secretion by diazoxide and reversible restoration by tolbutamide. Depolarization with tolbutamide or KCl (plus diazoxide) triggered rapid insulin secretion in 1 mmol/l glucose. Subsequent application of 15 mmol/l glucose further increased insulin secretion, showing that the amplifying pathway is operative. In control medium, glutamine alone was ineffective, but its combination with leucine or nonmetabolized 2-amino-bicyclo [2,2,1]-heptane-2-carboxylic acid (BCH) evoked rapid insulin secretion. The effect of BCH was larger in low glucose than in high glucose. In contrast, the insulin secretion response to arginine or a mixture of four amino acids was potentiated by glucose or tolbutamide. Palmitate slightly augmented insulin secretion only at the supraphysiological palmitate-to-albumin ratio of 5. Inosine and membrane-permeant analogs of pyruvate, glutamate, or succinate increased insulin secretion in 3 and 10 mmol/l glucose, whereas lactate and pyruvate had no effect. In conclusion, nutrient-induced insulin secretion in normal human islets is larger than often reported. Its characteristics are globally similar to those of insulin secretion by rodent islets, with both triggering and amplifying pathways. The pattern of the biphasic response to glucose is superimposable on that in mouse islets, but the concentration-response curve is shifted to the left, and various nutrients, in particular amino acids, influence insulin secretion within the physiological range of glucose concentrations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17130494     DOI: 10.2337/db06-0868

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  91 in total

Review 1.  The pyruvate carboxylase-pyruvate dehydrogenase axis in islet pyruvate metabolism: Going round in circles?

Authors:  Mary C Sugden; Mark J Holness
Journal:  Islets       Date:  2011-11-01       Impact factor: 2.694

2.  Differential expression of the glutamate transporter GLT-1 in pancreas.

Authors:  James S Meabon; Aven Lee; Kole D Meeker; Lynn M Bekris; Robert K Fujimura; Chang-En Yu; G Stennis Watson; David V Pow; Ian R Sweet; David G Cook
Journal:  J Histochem Cytochem       Date:  2011-11-22       Impact factor: 2.479

3.  Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics.

Authors:  Nicolai M Doliba; Wei Qin; Habiba Najafi; Chengyang Liu; Carol W Buettger; Johanna Sotiris; Heather W Collins; Changhong Li; Charles A Stanley; David F Wilson; Joseph Grimsby; Ramakanth Sarabu; Ali Naji; Franz M Matschinsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-09-27       Impact factor: 4.310

4.  Detailed protocol for evaluation of dynamic perifusion of human islets to assess β-cell function.

Authors:  Kwamina Bentsi-Barnes; Máire E Doyle; Danny Abad; Fouad Kandeel; Ismail Al-Abdullah
Journal:  Islets       Date:  2011-09-01       Impact factor: 2.694

Review 5.  Novel aspects of the molecular mechanisms controlling insulin secretion.

Authors:  Lena Eliasson; Fernando Abdulkader; Matthias Braun; Juris Galvanovskis; Michael B Hoppa; Patrik Rorsman
Journal:  J Physiol       Date:  2008-05-29       Impact factor: 5.182

6.  Glucose-stimulated insulin release: Parallel perifusion studies of free and hydrogel encapsulated human pancreatic islets.

Authors:  Peter Buchwald; Alejandro Tamayo-Garcia; Vita Manzoli; Alice A Tomei; Cherie L Stabler
Journal:  Biotechnol Bioeng       Date:  2017-09-19       Impact factor: 4.530

7.  Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells.

Authors:  Mourad Ferdaoussi; Xiaoqing Dai; Mette V Jensen; Runsheng Wang; Brett S Peterson; Chao Huang; Olga Ilkayeva; Nancy Smith; Nathanael Miller; Catherine Hajmrle; Aliya F Spigelman; Robert C Wright; Gregory Plummer; Kunimasa Suzuki; James P Mackay; Martijn van de Bunt; Anna L Gloyn; Terence E Ryan; Lisa D Norquay; M Julia Brosnan; Jeff K Trimmer; Timothy P Rolph; Richard G Kibbey; Jocelyn E Manning Fox; William F Colmers; Orian S Shirihai; P Darrell Neufer; Edward T H Yeh; Christopher B Newgard; Patrick E MacDonald
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

8.  NFAT targets signaling molecules to gene promoters in pancreatic β-cells.

Authors:  Michael C Lawrence; Nofit Borenstein-Auerbach; Kathleen McGlynn; Faisal Kunnathodi; Rauf Shahbazov; Ilham Syed; Mazhar Kanak; Morihito Takita; Marlon F Levy; Bashoo Naziruddin
Journal:  Mol Endocrinol       Date:  2014-12-12

Review 9.  Exocytosis mechanisms underlying insulin release and glucose uptake: conserved roles for Munc18c and syntaxin 4.

Authors:  Jenna L Jewell; Eunjin Oh; Debbie C Thurmond
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-01-06       Impact factor: 3.619

10.  Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects.

Authors:  Jerry R Greenfield; I Sadaf Farooqi; Julia M Keogh; Elana Henning; Abdella M Habib; Anthea Blackwood; Frank Reimann; Jens J Holst; Fiona M Gribble
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.